DataMeds AI Inc. Company Profile
NASDAQ: MEDSHealth CareOther PharmaceuticalsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
DataMeds AI at a glance
DataMeds AI Inc. (NASDAQ: MEDS) is a Other Pharmaceuticals company in the Health Care sector headquartered in Tampa, FL. DataMeds AI is led by Mr. Prashant Patel M.Sc., R.Ph.. The company's shares have traded publicly since 2025.
At a market capitalization of $8.4 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0002030763, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does DataMeds AI do?
DataMEDS AI, Inc. operates as a health IT company in the United States. The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for consumers. It offers tools, such as the EinsteinRx, a pharmacy dispensing AI platform; the PharmacyChain, a smart contracts platform; Patient Rx Adherence Tool; and HubRx AI. It also operates as a pharmacy distributor; and provides clinical concierge services. DataMEDS AI, Inc., through its subsidiary develops and delivers a portfolio of products to guide physicians and patients with difficult clinical decisions throughout the cancer care continuum. In addition, the company develops and provides functional precision medicine oncology platform. The company was formerly known as Wellgistics Health, Inc. and changed its name to DataMEDS AI, Inc. in July 2026. DataMEDS AI, Inc. was incorporated in 2022 and is based in Tampa, Florida.
Business description based on the company's public filings.
Company information
- Legal name
- DataMeds AI Inc.
- Ticker
- NASDAQ: MEDS
- Sector
- Health Care
- Industry
- Other Pharmaceuticals
- CEO
- Mr. Prashant Patel M.Sc., R.Ph.
- Headquarters
- 3000 Bayport Drive, Tampa, FL, United States
- Phone
- 844 203 6092
- Website
- datamedsai.com
- IPO year
- 2025
- Market cap
- $8.39M
- SEC CIK
- 0002030763
- Latest annual report
- 10-K/A · Apr 24, 2026
Companies similar to DataMeds AI
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| HKPDCellyan Biotechnology Co. Ltd Class A | 0.112 | +11.11% | $5.52M | vs MEDS |
| COSMCosmos Health Inc. | 0.3359 | +6.84% | $33.80M | vs MEDS |
| ESYNEnerSyn Global Inc. | 2.16 | +2.13% | $64.21M | vs MEDS |
| ZSTKZeroStack Corp. | 4.62 | -0.43% | $100.70M | vs MEDS |
| NUSNu Skin Enterprises Inc. | 4.74 | -0.63% | $230.73M | vs MEDS |
| HLFHerbalife Ltd. | 13.03 | +1.64% | $1.35B | vs MEDS |
| CAHCardinal Health Inc. | 237.57 | -0.58% | $55.01B | vs MEDS |
| CORCencora Inc. | 323.85 | +0.78% | $61.80B | vs MEDS |